Versant Capital Management, Inc Pfizer Inc Transaction History

Versant Capital Management, Inc

$431 Million
Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 4,434 shares of PFE stock, worth $116,880. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,434

Previous 3,482 27.34%

Holding current value

$116,880

Previous $97,000 31.96%

% of portfolio

0.03%

Previous 0.02%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$27.7 - $31.39 $26,370 - $29,883	952 Added 27.34%	4,434 $128,000
Q2 2024 Jul 05, 2024	SELL	$25.26 - $29.6 $4,369 - $5,120	-173 Reduced 4.73%	3,482 $97,000
Q1 2024 Apr 03, 2024	SELL	$25.89 - $29.73 $28,945 - $33,238	-1,118 Reduced 23.42%	3,655 $101,000
Q4 2023 Jan 08, 2024	BUY	$26.13 - $33.94 $13,665 - $17,750	523 Added 12.31%	4,773 $137,000
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $160 - $187	5 Added 0.12%	4,250 $140,000
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $3,864 - $4,471	107 Added 2.59%	4,245 $155,000
Q1 2023 Apr 10, 2023	BUY	$39.39 - $51.28 $40,808 - $53,126	1,036 Added 33.4%	4,138 $168,000
Q3 2022 Dec 30, 2022	BUY	$43.76 - $53.42 $1,706 - $2,083	39 Added 1.27%	3,102 $136,000
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $12,842 - $15,226	-276 Reduced 8.27%	3,063 $161,000
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $12,627 - $15,646	276 Added 9.01%	3,339 $173,000
Q4 2021 Jan 06, 2022	SELL	$41.32 - $61.25 $123,960 - $183,750	-3,000 Reduced 49.48%	3,063 $181,000
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $13,423 - $17,243	-342 Reduced 5.34%	6,063 $261,000
Q2 2021 Jul 22, 2021	SELL	$35.91 - $40.68 $62,698 - $71,027	-1,746 Reduced 21.42%	6,405 $251,000
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $100,670 - $113,536	3,006 Added 58.43%	8,151 $295,000
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $6,694 - $8,512	-200 Reduced 3.74%	5,145 $189,000
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $825 - $968	26 Added 0.49%	5,345 $196,000
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $1,807 - $2,192	-60 Reduced 1.12%	5,319 $173,000
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $4,297 - $6,140	159 Added 3.05%	5,379 $175,000
Q4 2019 Jan 28, 2020	SELL	$32.92 - $37.36 $22,846 - $25,927	-694 Reduced 11.73%	5,220 $204,000
Q3 2019 Oct 18, 2019	SELL	$32.49 - $42.13 $7,927 - $10,279	-244 Reduced 3.96%	5,914 $212,000
Q2 2019 Jul 16, 2019	SELL	$36.98 - $41.52 $65,898 - $73,988	-1,782 Reduced 22.44%	6,158 $266,000
Q1 2019 Apr 23, 2019	BUY	$37.5 - $41.2 $285,112 - $313,243	7,603 Added 2256.08%	7,940 $337,000
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $286,650 - $314,932	-7,644 Reduced 95.78%	337 $337,000
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $48,087 - $54,825	1,250 Added 18.57%	7,981 $348,000
Q3 2018 Oct 15, 2018	SELL	$34.47 - $41.81 $310 - $376	-9 Reduced 0.13%	6,731 $296,000
Q2 2018 Jul 06, 2018	SELL	$32.98 - $35.16 $3,199 - $3,410	-97 Reduced 1.42%	6,740 $244,000
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $5,648 - $6,552	-177 Reduced 2.52%	6,837 $242,000
Q4 2017 Apr 19, 2018	BUY	$33.26 - $35.29 $16,929 - $17,962	509 Added 7.82%	7,014 $254,000
Q3 2017 Apr 23, 2018	BUY	$31.0 - $34.15 $2,821 - $3,107	91 Added 1.42%	6,505 $232,000
Q2 2017 Apr 23, 2018	SELL	N/A	-156 Reduced 2.37%	6,414 $215,000
Q4 2016 Apr 23, 2018	SELL	N/A	-291 Reduced 4.24%	6,570 $213,000
Q3 2016 Apr 23, 2018	SELL	N/A	-132 Reduced 1.89%	6,861 $232,000
Q2 2016 Apr 23, 2018	SELL	N/A	-56 Reduced 0.79%	6,993 $246,000
Q1 2016 Apr 23, 2018	SELL	N/A	-583 Reduced 7.64%	7,049 $208,000
Q4 2015 Apr 23, 2018	BUY	N/A	7,632	7,632 $246,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Pfizer Inc Transaction History